NCT07863791CompletedPhase 2
Effect of Omega 3 Fatty Acids on Heart and Liver in Beta Thalassemia Patients
Effect of Omega 3 Fatty Acids on Hepatic and Cardiac Iron Burden and Organic Function in Children and Adolescent With Transfusion Dependent Beta Thalassemia:A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
the aim of this interventional study to show the effect of taking omega 3 for about 6 months for patients beta thalassemia major maintained on standard of care and receiving the iron chelator deferasirox on liver, cardiac functions and transfusion index the patients randomly distributed to two groups group A receiving the omega 3 in dose 1gram pr day(50 patients) group b not receiving the drug
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 20 Sept 2026
- Start date
- Jan 2026
- Primary completion date
- Aug 2026
- Lead sponsor
- Ain Shams University
- Diseases
- Thalassaemia
- NCT number
- NCT07863791
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 100
- From Jan 2026 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- patients with infection or other inflammatory conditions patient with active hepatitis(serum transaminases\>3 times above upper limit of normal) participation in previous clinical trial or supplementation with antioxidants or vitamins with three months prior to study
Who the study is looking for
- age: 6-18 years old children and adolescents with transfusion dependent thalassemia(TDT).diagnosis of TDT is based on clinical severity and transfsion requirements according to thalassemia international federation(TIF)guidelines
Age in the registry: 6 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ain Shams University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.